BioCryst Pharmaceuticals, Inc. Share Price
Stocks
BCRX
US09058V1035
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.990 USD | +0.45% |
|
+3.33% | +15.26% |
| Market Cap | 228.49Cr 199.22Cr 184.51Cr 172.73Cr 323.94Cr 22TCr 325.9Cr 2.19TCr 848.32Cr 11TCr 857.69Cr 839.3Cr 37TCr | P/E 2026 * |
-3.75x | P/E 2027 * | 30.9x |
|---|---|---|---|---|---|
| Enterprise Value | 228.49Cr 199.22Cr 184.51Cr 172.73Cr 323.94Cr 22TCr 325.9Cr 2.19TCr 848.32Cr 11TCr 857.69Cr 839.3Cr 37TCr | EV / Sales 2026 * |
3.41x | EV / Sales 2027 * | 3.14x |
| Free-Float |
94.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | +0.45% | ||
| 1 week | +3.33% | ||
| Current month | +0.90% | ||
| 1 month | +2.51% | ||
| 3 months | -8.36% | ||
| 6 months | +21.32% | ||
| Current year | +15.26% |
| 1 week | 8.7 |  | 9.54 |
| 1 month | 8.06 | | 9.54 |
| Current year | 6.23 | | 10.32 |
| 1 year | 6 | | 10.32 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 01/01/2026 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 07/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | - | 06/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 01/01/2007 |
Theresa Heggie
BRD | Director/Board Member | 65 | 03/12/2018 |
Charles Gayer
BRD | Director/Board Member | 55 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/06 | Free | Director | 48,834 | 0.0192% | ||
| 11/06 | Free | Director | 48,834 | 0.0192% | ||
| 11/06 | Free | Director | 48,834 | 0.0192% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.45% | +3.33% | -9.74% | +21.32% | 228.49Cr | |
| +1.44% | -1.25% | +63.52% | +114.88% | 5.52TCr | |
| +4.60% | +3.02% | +58.20% | +47.16% | 4.58TCr | |
| -1.44% | +0.39% | -12.94% | -19.24% | 2.3TCr | |
| -2.69% | -2.10% | -3.68% | +379.00% | 2.08TCr | |
| +3.22% | -0.84% | +27.88% | -34.00% | 1.63TCr | |
| +0.58% | +1.08% | +16.73% | -38.06% | 1.54TCr | |
| -1.01% | -2.30% | +27.42% | +171.92% | 1.3TCr | |
| +4.95% | +11.70% | +123.63% | +252.19% | 1.24TCr | |
| +3.07% | +0.14% | +29.37% | - | 1.24TCr | |
| Average | +1.32% | +2.58% | +32.04% | +99.46% | 2.17TCr | |
| Weighted average by Cap. | +1.62% | +1.52% | +40.38% | +99.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67Cr 59Cr 54Cr 51Cr 95Cr 6.33TCr 96Cr 642.83Cr 249.13Cr 3.12TCr 251.88Cr 246.48Cr 11TCr | 73Cr 63Cr 59Cr 55Cr 103.1Cr 6.86TCr 103.72Cr 696.66Cr 270Cr 3.38TCr 272.98Cr 267.12Cr 12TCr |
| Net income | -67Cr -59Cr -54Cr -51Cr -96Cr -6.36TCr -96Cr -645.62Cr -250.21Cr -3.13TCr -252.98Cr -247.55Cr -11TCr | 4.19Cr 3.65Cr 3.38Cr 3.17Cr 5.94Cr 395.3Cr 5.98Cr 40Cr 16Cr 194.57Cr 16Cr 15Cr 675.61Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | 8.990 $ | +0.45% | 88,82,726 |
| 17/26/17 | 8.950 $ | +0.34% | 44,50,756 |
| 16/26/16 | 8.920 $ | -1.55% | 35,75,476 |
| 15/26/15 | 9.060 $ | +4.14% | 41,53,927 |
| 12/26/12 | 8.700 $ | +2.35% | 23,94,656 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
